Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms
Open Access
- 10 March 2016
- journal article
- Published by American Society of Hematology in Blood
- Vol. 127 (10), 1307-1316
- https://doi.org/10.1182/blood-2015-09-671172
Abstract
Recurrent somatic mutations of calreticulin (CALR) have been identified in patients harboring myeloproliferative neoplasms (MPNs); however their role in tumorigenesis remains elusive. Here, we found that the expression of mutant but not wild-type CALR induces the thrombopoietin (TPO)-independent growth of UT-7/TPO cells. We demonstrated that c-MPL, the TPO receptor, is required for this cytokine-independent growth of UT-7/TPO cells. Mutant CALR preferentially associates with c-MPL that is bound to JAK2 over the wild-type protein. Furthermore, we demonstrated that the mutant-specific C-terminus portion of CALR interferes with the P-domain of CALR to allow the N-domain to interact with c-MPL, providing an explanation for the gain-of-function property of mutant CALR. We showed that mutant CALR induces the phosphorylation of JAK2 and its downstream signaling molecules in UT-7/TPO cells and that this induction was blocked by JAK2 inhibitor treatment. Finally, we demonstrated that c-MPL is required for TPO-independent megakaryopoiesis in iPS-derived hematopoietic stem cells harboring the CALR mutation. These findings imply that mutant CALR activates the JAK2 downstream pathway via its association with c-MPL. Considering these results, we propose that mutant CALR promotes MPN development by activating c-MPL and its downstream pathway.Keywords
This publication has 25 references indexed in Scilit:
- JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomesBlood, 2014
- Strange attractors: DAMPs and autophagy link tumor cell death and immunityCell Death & Disease, 2013
- Inhibition of the NAD-Dependent Protein Deacetylase SIRT2 Induces Granulocytic Differentiation in Human Leukemia CellsPLOS ONE, 2013
- Calreticulin and CancerPathology and Oncology Research, 2013
- Tryptophan at the transmembrane–cytosolic junction modulates thrombopoietin receptor dimerization and activationProceedings of the National Academy of Sciences of the United States of America, 2013
- An Efficient Nonviral Method to Generate Integration-Free Human-Induced Pluripotent Stem Cells from Cord Blood and Peripheral Blood CellsThe International Journal of Cell Cloning, 2012
- Thrombopoietin receptor activation: transmembrane helix dimerization, rotation, and allosteric modulationThe FASEB Journal, 2011
- Calreticulin: non‐endoplasmic reticulum functions in physiology and diseaseThe FASEB Journal, 2009
- Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulumBiochemical Journal, 2009
- The calcium-binding protein calreticulin is a major constituent of lytic granules in cytolytic T lymphocytes.The Journal of Experimental Medicine, 1993